Legal Opinion
Meijer, Inc. v. Biovail Corp.
Court of Appeals for the D.C. Circuit
Decided July 25, 2008No. 05-7066, 05-7069, 05-7084, 06-7118PublishedCited by 84 opinions
1Opinion of the Court
Opinion for the Court filed by Circuit Judge GINSBURG.
GINSBURG, Circuit Judge:
The plaintiff-appellants in these four antitrust class actions are wholesale purchasers of Tiazac (extended-release Diltiazem Hydrochloride, hereinafter Diltiazem HC1), a controlled-release drug for hypertension and angina. They alleged that Biovail Corporation, which manufactures Tiazac, misused a patent to keep off the market a generic equivalent manufactured by Andrx Pharmaceuticals, Inc., in violation of federal and state antitrust laws. The district court entered summary judgment for Bio-vail, which we affirm.
I.…
2Cases cited25 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Brunswick Corp. v. Pueblo Bowl-O-Mat, Inc.Supreme Court of the United States · 1977
- Zenith Radio Corp. v. Hazeltine Research, Inc.Supreme Court of the United States · 1969
- Ciralsky v. Central Intelligence AgencyCourt of Appeals for the D.C. Circuit · 2004
- Atlantic Richfield Co. v. USA Petroleum Co.Supreme Court of the United States · 1990
20 more not listed; retrieve them via the Exa API.
3Cited by84 opinions
- Jones v. BernankeCourt of Appeals for the D.C. Circuit · 2009
- Glover v. Federal Deposit InsuranceCourt of Appeals for the Third Circuit · 2012
- Richard Dominguez v. Ual CorporationCourt of Appeals for the D.C. Circuit · 2012
- Blackmon-Malloy v. United States Capitol Police BoardCourt of Appeals for the D.C. Circuit · 2009
- United States ex rel. Miller v. Bill Harbert International Construction, Inc.Court of Appeals for the D.C. Circuit · 2010
79 more not listed; retrieve them via the Exa API.